208 related articles for article (PubMed ID: 33612479)
1. Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
Huang J; Zhang Q; Shen J; Chen X; Ma S
Aging (Albany NY); 2021 Feb; 13(4):5946-5966. PubMed ID: 33612479
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of AURKB gene in lung adenocarcinoma: Analysis based on the data-mining of bioinformatic database.
Gao X; Jiang A; Shen Y; Lu H; Chen R
Medicine (Baltimore); 2021 Aug; 100(31):e26439. PubMed ID: 34397793
[TBL] [Abstract][Full Text] [Related]
3. The Regulation of let-7c-5p on the Biological Characteristics of Lung Adenocarcinoma Cells by Targeting AURKB.
Wang L; Xiao X; Du H
Mol Biotechnol; 2022 May; 64(5):526-534. PubMed ID: 34997902
[TBL] [Abstract][Full Text] [Related]
4. microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB.
Sun G; Ni K; Shen J; Liu D; Wang H
Crit Rev Eukaryot Gene Expr; 2024; 34(4):13-23. PubMed ID: 38505869
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma.
Zhang J; Ma J; Li Y; An Y; Du W; Yang Q; Huang M; Cai X
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396874
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
7. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
8. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
9.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
10. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
12. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
Li L; Jiang P; Hu W; Zou F; Li M; Rao T; Ruan Y; Yu W; Ning J; Cheng F
J Transl Med; 2024 Mar; 22(1):295. PubMed ID: 38515112
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
14. AURKB promotes gastric cancer progression via activation of
Nie M; Wang Y; Yu Z; Li X; Deng Y; Wang Y; Yang D; Li Q; Zeng X; Ju J; Liu M; Zhao Q
Aging (Albany NY); 2020 Jan; 12(2):1304-1321. PubMed ID: 31982864
[TBL] [Abstract][Full Text] [Related]
15. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer.
Hu T; Wang X; Xia Y; Wu L; Ma Y; Zhou R; Zhao Y
Chin Med J (Engl); 2022 Sep; 135(18):2218-2231. PubMed ID: 36113844
[TBL] [Abstract][Full Text] [Related]
17. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
18. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.
Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q
Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050
[TBL] [Abstract][Full Text] [Related]
19. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
Fan K; Zhang BH; Han D; Sun YC
BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
[TBL] [Abstract][Full Text] [Related]
20. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]